Status:
COMPLETED
PortoSinusoidal Vascular Diseases and Systemic Sclerosis
Lead Sponsor:
University Hospital, Caen
Conditions:
PSVD With or Without SSc
Eligibility:
All Genders
18+ years
Brief Summary
Porto-Sinusoidal Vascular Disorders (PSVD) is a heterogeneous clinico-pathological entity characterized by alterations in small liver vessels. "Nodular regenerative hyperplasia (NRH)" is the most comm...
Detailed Description
The study aims to compare the outcome of patients with MVPS associated with SSc to patients with MVPS without SSc. This work is a multicenter retrospective study comparing two groups of adult patients...
Eligibility Criteria
Inclusion
- PSVD (Valdig criteria)
- SSC (ACR/EULAR 2013 criteria)
Exclusion
- Liver cirrhosis
- Limited scleroderma
- Autoimmune hepatitis
- Primary biliary cholangitis
Key Trial Info
Start Date :
February 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 29 2024
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT06032754
Start Date
February 1 2023
End Date
March 29 2024
Last Update
June 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu de Caen
Caen, Calvados, France, 14000